Mevalonate pathway targets FoxM1 transcription factor via protein geranylgeranylation in human hepatocellular carcinoma

被引:0
|
作者
Ogura, Satoshi [1 ]
Yoshida, Yuichi [1 ]
Egawa, Mayumi [1 ]
Kurahashi, Tomohide [1 ]
Furuta, Kunimaro [1 ]
Kiso, Shinichi [1 ]
Kamada, Yoshihiro [1 ]
Takehara, Tetsuo [1 ]
机构
[1] Osaka Univ, Dept Gastroenterol & Hepatol, Suita, Osaka, Japan
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
1974
引用
收藏
页码:1169A / 1169A
页数:1
相关论文
共 50 条
  • [1] Lipid metabolism regulates oncogenic FoxM1 transcription factor in human hepatocellular carcinoma via the mevalonate-Rho pathway
    Yoshida, Yuichi
    Ogura, Satoshi
    Kurahashi, Tomohide
    Egawa, Mayumi
    Furuta, Kunimaro
    Kiso, Shinichi
    Kamada, Yoshihiro
    Hikita, Hayato
    Tatsumi, Tomohide
    Takehara, Tetsuo
    HEPATOLOGY, 2017, 66 : 974A - 974A
  • [2] Metabolic regulation of FoxM1 transcription factor by mevalonate-Rho pathways in human hepatocellular carcinoma
    Ogura, Satoshi
    Yoshida, Yuichi
    Kurahashi, Tomohide
    Egawa, Mayumi
    Furuta, Kunimaro
    Kiso, Shinichi
    Kamada, Yoshihiro
    Hikita, Hayato
    Tatsumi, Tomohide
    Takehara, Tetsuo
    HEPATOLOGY, 2016, 64 : 248A - 248A
  • [3] Crucial role of FoxM1 transcription factor as a predictor of clinical outcomes in patients with hepatocellular carcinoma
    Egawa, Mayumi
    Yoshida, Yuichi
    Kiso, Shinichi
    Tomokuni, Akira
    Kizu, Takashi
    Furuta, Kunimaro
    Takemura, Takayo
    Hamano, Mina
    Chatani, Norihiro
    Ezaki, Hisao
    Kamada, Yoshihiro
    Nagano, Hiroaki
    Doki, Yuichiro
    Mori, Masaki
    Takehara, Tetsuo
    HEPATOLOGY, 2012, 56 : 275A - 275A
  • [4] Transcription factor FOXM1 promotes hepatocellular carcinoma malignant progression through activation of the WNT pathway by binding to SETDB1
    Kong, Jianqiao
    Xu, Song
    Deng, Zhongming
    Wang, Yi
    Zhang, Peng
    TISSUE & CELL, 2023, 84
  • [5] Silencing of FOXM1 transcription factor expression by adenovirus-mediated RNA interference inhibits human hepatocellular carcinoma growth
    T Chen
    J Xiong
    C Yang
    L Shan
    G Tan
    L Yu
    Y Tan
    Cancer Gene Therapy, 2014, 21 : 133 - 138
  • [6] Silencing of FOXM1 transcription factor expression by adenovirus-mediated RNA interference inhibits human hepatocellular carcinoma growth
    Chen, T.
    Xiong, J.
    Yang, C.
    Shan, L.
    Tan, G.
    Yu, L.
    Tan, Y.
    CANCER GENE THERAPY, 2014, 21 (03) : 133 - 138
  • [7] TARGETING FOXM1 TRANSCRIPTION FACTOR IN RHABDOMYOSARCOMA
    Dolan, J. G.
    Wan, X.
    Yeung, C.
    Helman, L. J.
    JOURNAL OF INVESTIGATIVE MEDICINE, 2011, 59 (01) : 183 - 183
  • [8] A cell penetrating ARF peptide inhibitor of the Foxm1 transcription factor is an effective treatment for hepatocellular carcinoma in vivo
    Costa, Robert H.
    Gusarova, Galina A.
    Wang, I-Ching
    Major, Michael L.
    Kalinichenko, Vladimir V.
    Ackerson, Timothy
    Petrovic, Vladimir
    CANCER RESEARCH, 2006, 66 (08)
  • [9] The oncogenic transcription factor FOXM1 and anticancer therapy
    Gartel, Andrei L.
    CELL CYCLE, 2012, 11 (18) : 3341 - +
  • [10] FOXM1 Upregulates O-GlcNAcylation Level Via The Hexosamine Biosynthesis Pathway to Promote Angiogenesis in Hepatocellular Carcinoma
    Zhang, Xiaorong
    Zhong, Yifan
    Yang, Qing
    CELL BIOCHEMISTRY AND BIOPHYSICS, 2024, 82 (03) : 2767 - 2785